Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Ferrari NV (RACE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Ferrari NV — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while Ferrari NV trades at $390.62 (market cap $68.43B). The key difference: Ferrari NV is far larger — about 7.7× Kymera Therapeutics Inc. Common Stock's market cap, and Ferrari NV pays a 1.09% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Ferrari NV for 126 Days on average.
| KYMR | RACE | |
|---|---|---|
Market Cap | $8.88B | $68.43B |
Volume | 1,028,790 | 343,086 |
Sector | Health | Consumer Cyclical |
52-Week High | $127.31 | $436.54 |
52-Week Low | $55.80 | $314.63 |
Typical Hold Time | 0 Days | 126 Days |
Enterprise Value | $8.27B | $70.30B |
Dividend Yield | — | 1.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Ferrari (RACE) trades at $391.60, up 0.61% with strong fundamentals including 22.25% net margins and consistent earnings beats. The stock shows bearish technical signals despite positive analyst sentiment with a $462.75 consensus target. Recent news highlights institutional buying and a €250 million share buyback program, while financials reveal robust revenue growth from $5.1B in 2022 to $7.15B in 2025.
Outlook remains positive given Ferrari's premium brand positioning and earnings momentum, though valuation multiples appear stretched with a P/E of 37.4. Key risks include economic sensitivity to luxury demand and execution of electric vehicle initiatives. The 18% upside to analyst targets suggests potential reward, but investors should weigh high valuations against growth sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Ferrari NV
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →
